Intra-Cellular Therapies Statistics
Total Valuation
FLMNY has a market cap or net worth of 5.37 billion. The enterprise value is 6.28 billion.
| Market Cap | 5.37B |
| Enterprise Value | 6.28B |
Important Dates
The next estimated earnings date is Thursday, August 28, 2025.
| Earnings Date | Aug 28, 2025 |
| Ex-Dividend Date | Jul 14, 2025 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.64% |
| Shares Change (QoQ) | +0.57% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 22.76M |
Valuation Ratios
The trailing PE ratio is 30.56 and the forward PE ratio is 21.63.
| PE Ratio | 30.56 |
| Forward PE | 21.63 |
| PS Ratio | 2.13 |
| PB Ratio | 5.44 |
| P/TBV Ratio | 30.35 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 35.73 |
| EV / Sales | 2.34 |
| EV / EBITDA | 11.14 |
| EV / EBIT | 19.88 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.96 |
| Debt / EBITDA | 1.79 |
| Debt / FCF | n/a |
| Interest Coverage | 5.79 |
Financial Efficiency
Return on equity (ROE) is 18.64% and return on invested capital (ROIC) is 10.58%.
| Return on Equity (ROE) | 18.64% |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 10.58% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 112,912 |
| Profits Per Employee | 7,885 |
| Employee Count | 24,363 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, FLMNY has paid 76.22 million in taxes.
| Income Tax | 76.22M |
| Effective Tax Rate | 30.02% |
Stock Price Statistics
The stock price has increased by +37.43% in the last 52 weeks. The beta is 0.46, so FLMNY's price volatility has been lower than the market average.
| Beta (5Y) | 0.46 |
| 52-Week Price Change | +37.43% |
| 50-Day Moving Average | 9.63 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 60.18 |
| Average Volume (20 Days) | 1,046 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, FLMNY had revenue of 2.52 billion and earned 175.77 million in profits. Earnings per share was 2.10.
| Revenue | 2.52B |
| Gross Profit | 2.02B |
| Operating Income | 295.58M |
| Pretax Income | 253.91M |
| Net Income | 175.77M |
| EBITDA | 405.53M |
| EBIT | 295.58M |
| Earnings Per Share (EPS) | 2.10 |
Balance Sheet
The company has 109.90 million in cash and 944.50 million in debt, giving a net cash position of -834.60 million.
| Cash & Cash Equivalents | 109.90M |
| Total Debt | 944.50M |
| Net Cash | -834.60M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 986.97M |
| Book Value Per Share | 11.57 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 80.30%, with operating and profit margins of 11.74% and 6.98%.
| Gross Margin | 80.30% |
| Operating Margin | 11.74% |
| Pretax Margin | 10.09% |
| Profit Margin | 6.98% |
| EBITDA Margin | 16.11% |
| EBIT Margin | 11.74% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.14, which amounts to a dividend yield of 1.08%.
| Dividend Per Share | 0.14 |
| Dividend Yield | 1.08% |
| Dividend Growth (YoY) | 2.01% |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | 0.64% |
| Shareholder Yield | 1.72% |
| Earnings Yield | 3.27% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |